Market revenue in 2023 | USD 1.6 million |
Market revenue in 2030 | USD 2.2 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 25% in 2024. Horizon Databook has segmented the Sweden dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
The availability of DBS collection cards from multiple manufacturers in Sweden suggests that there is a strong demand for these products in the healthcare and research sectors. The use of DBS collection cards in Sweden has evolved beyond its original application in newborn screening programs, and these products are now used in a range of applications across the healthcare and biomedical research industries.
In Sweden, prenatal testing for CAH began in 1986. Since then, about 3.5 million infants have undergone screening. In Sweden, one national screening lab handles more than 100,000 samples annually. More than 99.5% of all infants in Sweden are screened, despite the fact that it is not required.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden dried blood spot collection cards market , including forecasts for subscribers. This country databook contains high-level insights into Sweden dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account